![Roche Alzheimer’s Early Detection Tests Get FDA Green Light](https://www.g2intelligence.com/wp-content/uploads/2022/12/Jan23.DTET_.NewProductsPipeline.formerlyFDAWatch-iStock-1800x1250-1-1080x675.jpg)
Roche Alzheimer’s Early Detection Tests Get FDA Green Light
In this month’s diagnostics pipeline report, Roche gets clearance for two new Alzheimer’s early detection tests.
In this month’s diagnostics pipeline report, Roche gets clearance for two new Alzheimer’s early detection tests.
Advances in MALDI time-of-flight mass spectrometry have significantly expanded its use in high-throughput diagnostic labs.
A decline in COVID-19 testing demand, along with a challenging economy, made for a difficult quarter for diagnostics companies.
Though only seven transactions were announced or closed in November, two were billion-dollar deals.
M&A deals in the diagnostics industry have been lower in number, but higher in impact in recent months.